Multiscale Models for New Antibiotic Technologies

1 hour 6 mins,  485.13 MB,  WebM  640x360,  29.97 fps,  44100 Hz,  0.98 Mbits/sec
Share this media item:
Embed this media item:


About this item
media item has no image
Description: Kaznessis, Y
Tuesday 12th April 2016 - 15:00 to 16:00
 
Created: 2016-04-19 17:15
Collection: Stochastic Dynamical Systems in Biology: Numerical Methods and Applications
Publisher: Isaac Newton Institute
Copyright: Kaznessis, Y
Language: eng (English)
Distribution: World     (downloadable)
Explicit content: No
Aspect Ratio: 16:9
Screencast: No
Bumper: UCS Default
Trailer: UCS Default
 
Abstract: Antibiotic-resistant bacterial infections are significant causes of morbidity and mortality worldwide. These infections kill over 700,000 people globally every year. Because of the paucity of new antibiotics, this number may increase to over 10 million by 2050, surpassing deaths from cancer and diabetes combined (http://amr-review.org/). Using synthetic biology techniques, we engineer probiotic bacteria to produce antimicrobial peptides (AMPs) and deliver the potent antibiotic proteins in the gastrointestinal tract of hosts. We test this new technology and demonstrate that it safely reduces multi-drug resistant pathogenic bacteria in the gut of animals [1,2]. At the heart of biological engineering efforts are multiscale models that guide explanations and predictions of the antagonistic activity of recombinant LAB against pathogenic strains [3]. Models are developed to quantify how AMPs kill bacteria at distinct but tied scales. Using atomistic simulations the various interaction steps between peptides and cell membranes are explored. Mesoscopic models are developed to study ion transport and depolarization of membranes treated with AMPs [4]. Stochastic kinetic models are developed to quantify the strength of synthetic promoters and AMPs expression [5]. In this presentation, we will discuss how modeling facilitates biological engineering and stress important theoretical and numerical challenges.
References

Volzing K, Borrero J, Sadowsky MJ, Kaznessis YN. “Antimicrobial Peptides Targeting Gram-negative Pathogens, Produced and Delivered by Lactic Acid Bacteria.” ACS Synth Biol. 2013. 15;2(11):643-50. doi: 10.1021/sb4000367 .
Geldart K., Borrero J., Kaznessis Y.N., “A Chloride-Inducible Expression Vector for Delivery of Antimicrobial Peptides Against Antibiotic-Resistant Enterococcus faecium”, Applied and Environmental Microbiology, 2015 81:11 3889-3897.3.
Kaznessis Y, “Multiscale Models of Antibiotic Probiotics”, Curr Opin Chem Eng, 2014, 1;6:18-24
Bolintineanu D, Kaznessis YN. "Computational studies of protegrin antimicrobial peptides: a review." Peptides. 2011 Jan;32(1):188-201
Kaznessis YN. Computational methods in synthetic biology. Biotechnol J. 2009 Oct;4(10):1392-405. doi: 10.1002/biot.200900163.
Available Formats
Format Quality Bitrate Size
MPEG-4 Video 640x360    1.91 Mbits/sec 945.55 MB View Download
WebM * 640x360    0.98 Mbits/sec 485.13 MB View Download
iPod Video 480x270    491.54 kbits/sec 237.61 MB View Download
MP3 44100 Hz 250.51 kbits/sec 121.10 MB Listen Download
Auto (Allows browser to choose a format it supports)